Mursla unveils new bead-nanochip technology for ultrasensitive and high throughput exosome detection
Novel technology further establishes Mursla’s capabilities to uniquely analyse exosome biology for clinical translation
-
Inventor and trained in biophysics at the University of Cambridge (Cavendish Lab)
-
Previously spent 10 years in healthcare investment banking at J.P. Morgan
-
Closed >20 transactions with deal value >$70B
-
Received his Master of Science in Management from HEC Paris
Pierre Arsène
Founder & CEO
-
Trained in cancer biology and exosomes at MD Anderson (Kalluri Lab) as well as microfluidics and sensors at INESC Microsystems & Nanotechnologies
-
Received his Ph.D. in Bioengineering Systems - MIT Portugal programme
Tomás Dias, PhD
CTO
-
Research focused on quantum phenomena in biofluids
-
Received his Ph.D. in Physics from the University of Cambridge
Adrian Ionescu, PhD
Senior Research Associate
-
Work focused on assay optimization
-
Followed postgraduation programme in Pharmaceutical Marketing & Business Development at the Lisbon School of Economics and Management
-
Received his Bachelor in Biology from the University of Coimbra
Ricardo Figueiras
Research Associate
-
Work focused on biosensor and nanosensor optimization
-
Received her MRes in Bioengineering from Imperial College London
Yu-Hsien Hung
Research Associate
-
Work focused on cell culture and assay optimization
-
Received her Master in Biotechnology from Instituto Superior Tecnico
Susana Vagueiro
Research Associate
-
Work focused on micro- and nanofabrication processes
-
Received his MEng in Micro and Nanotechnology from Grenoble Institute of Technology
Renato Almeida
Research Associate
-
Work focused on assay development and biolab support
-
Received her Master in Genomic Medicine from King's College London
Elnaz Persia
Research Assistant
-
Work focused on assisting the CEO and the rest of the team
-
Received her Master in International Economy from Moscow State University
Valerie O'Connor
Admin assistant
Team
About
Our mission is to offer life-saving clinical insights to patients and their medical teams.
Advisors
-
10 years of experience in automatizing liquid biopsy solutions, including for exosomes
-
COO at Xilis and previous work experience at Guardant Health and Freenome
-
Received his Ph.D. in biomedical engineering from Carnegie Mellon University
Daniel Delubac, PhD
Liquid biopsy automation expert
-
Global scientific leader on exosome applications
-
Professor at the Institute of Transfusion Medicine, University of Essen
-
Over 100 publications, including half on exosomes
-
Received his Ph.D. in biology at the University of Cologne
Bernd Giebel, PhD
Exosome expert
-
Leading research group dedicated to the study of the role of vessels in liver disease as well as the role of exosomes
-
Professor of Hepatology at the University of Paris
-
Received his Ph.D. in vascular biology and MD at the University of Paris 7
PE Rautou, MD PhD
Clinical expert
-
Team leader target and pathway discovery at Galapagos
-
Prior research on high-throughput proteomics to study tissue remodelling in disease
-
Received his Ph.D. in Protein Biochemistry from Imperial College London
Thanos Didangelos, PhD
Biomarker discovery expert
-
Professor in single electron transistor devices at Tokyo Institute of Technology
-
Previous work experience at Toshiba
-
Received his Ph.D. in Physical Electronics from Tokyo Institute of Technology
Yutaka Majima, PhD
Nanofabrication expert
OUR NEWS
Want to partner with us?
.png)
OUR PARTNERS
Supporting world-class research
